The world is full of tradeoffs—it’s the way progress is made while proportionately managing ...
2023 is poised to be a transformative year for the pharma industry, even more ...
Getting clinical trials to the finish line is not easy. Between 15% to 40% ...
PM360 asked experts in clinical trials about the evolution of decentralized research and what ...
Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...
Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar ...
In the pharmaceutical business, as with any other business, you can’t market what you ...
The biotech sector has seen its fair share of unsettling dynamics over the past ...
Selecting the right Contract Research Organization (CRO) for your clinical trial is a common ...
Substantial unmet needs exist in the diagnosis and treatment of gynecologic cancers. Often, these ...
Clinical trial recruitment is a lengthy and complex process involving stringent protocols and the ...
While digital therapeutics (DTx) companies are extremely optimistic about the promise of software-based interventions ...